COVID-19: people who have had infection might only need one dose of mRNA vaccine

Single Dose Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2

(2021) · doi:10.1101/2021.01.30.21250843 · Cited by 364 · see citing works

Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2

Saadat, S., Rikhtegaran Tehrani, Z., Logue, J., Newman, M., Frieman, M. B., Harris, A. D., & Sajadi, M. M. (2021) · JAMA · doi:10.1001/jama.2021.3341 · Cited by 364 · see citing works

Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine

Krammer, F., Srivastava, K., the PARIS team, & Simon, V. (2021) · doi:10.1101/2021.01.29.21250653 · Cited by 116 · see citing works

Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study

Menni, C., Klaser, K., May, A., Polidori, L., Capdevila, J., Louca, P., Sudre, C. H., Nguyen, L. H., Drew, D. A., Merino, J., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00224-3 · Cited by 1,031 · see citing works

Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers

Kremsner, P., Mann, P., Bosch, J., Fendel, R., Gabor, J. J., Kreidenweiss, A., Kroidl, A., Leroux-Roels, I., Leroux-Roels, G., Schindler, C., et al. (2020) · doi:10.1101/2020.11.09.20228551 · Cited by 199 · see citing works

SARS-CoV-2 antibody response in persons with past natural infection

Anichini, G., Terrosi, C., Gandolfo, C., Gori Savellini, G., Fabrizi, S., Miceli, G. B., & Cusi, M. G. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2103825 · Cited by 141 · see citing works

First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19

Mazzoni, A., Di Lauria, N., Maggi, L., Salvati, L., Vanni, A., Capone, M., Lamacchia, G., Mantengoli, E., Spinicci, M., Zammarchi, L., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149150 · Cited by 139 · see citing works

Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID

Weaver, K. N., Zhang, X., Dai, X., Watkins, R. D., Adler, J., Dubinsky, M. C., Kastl, A., Bousvaros, A., Strople, J. A., Cross, R. K., et al. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab302 · Cited by 93 · see citing works

Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran

Babamahmoodi, F., Saeedi, M., Alizadeh‐Navaei, R., Hedayatizadeh‐Omran, A., Mousavi, S. A., Ovaise, G., Kordi, S., Akbari, Z., Azordeh, M., Ahangarkani, F., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00963-7 · Cited by 76 · see citing works

B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19

Zollner, A., Watschinger, C., Rössler, A., Farcet, M. R., Penner, A., Böhm, V., Zollner-Kiechl, S., Stampfel, G., Hintenberger, R., Tilg, H., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103539 · Cited by 75 · see citing works

The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa

Osuagwu, U. L., Mashige, K. P., Ovenseri-Ogbomo, G. O., Envuladu, E. A., Abu, E. K., Miner, C. A., Timothy, C. G., Ekpenyong, B. N., Langsi, R., Amiebenomo, O. M.-A., et al. (2023) · BMC Public Health · doi:10.1186/s12889-022-14972-2 · Cited by 74 · see citing works

Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary

Tré‐Hardy, M., Cupaiolo, R., Wilmet, A., Antoine-Moussiaux, T., Vecchia, A. D., Horeanga, A., Papleux, E., Vekemans, M., Beukinga, I., & Blairon, L. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.08.031 · Cited by 69 · see citing works

Active Surveillance of Adverse Events in Healthcare Workers Recipients After Vaccination with COVID-19 BNT162b2 Vaccine (Pfizer-BioNTech, Comirnaty): A Cross-Sectional Study

Ripabelli, G., Tamburro, M., Buccieri, N., Adesso, C., Caggiano, V., Cannizzaro, F., Palma, M. A. D., Mantuano, G., Montemitro, V. G., Natale, A., et al. (2021) · Journal of Community Health · doi:10.1007/s10900-021-01039-3 · Cited by 57 · see citing works

SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people

Narowski, T. M., Raphel, K., Adams, L. E., Huang, J., Vielot, N. A., Jadi, R., de Silva, A. M., Baric, R. S., Lafleur, J., & Premkumar, L. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110336 · Cited by 51 · see citing works

Spike Antibody Levels of Nursing Home Residents With or Without Prior COVID-19 3 Weeks After a Single BNT162b2 Vaccine Dose

Blain, H., Tuaillon, É., Gamon, L., Pisoni, A., Miot, S., Picot, M., & Bousquet, J. (2021) · JAMA · doi:10.1001/jama.2021.6042 · Cited by 48 · see citing works

Quantitative Analysis of Anti-N and Anti-S Antibody Titers of SARS-CoV-2 Infection after the Third Dose of COVID-19 Vaccination

Lee, N., Jeong, S., Lee, S. K., Cho, E., Hyun, J., Park, M.-J., Song, W., & Kim, H. S. (2022) · Vaccines · doi:10.3390/vaccines10071143 · Cited by 35 · see citing works

Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges

Viana, J. F., Bergman, M., Gonçalves, L. A., Duarte, N., Coutinho, T. P., Borges, P., Diwo, C., Castro, R., Matoso, P., Malheiro, V., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27761-z · Cited by 34 · see citing works

Side-effects of COVID-19 vaccines among the Saudi population

Almughais, E. S., Alharbi, A. H., Aldarwish, H. A., Alshammari, A. F., Alsuhaymi, R. S., Almuaili, J., & Alanizy, A. M. (2022) · Saudi Medical Journal · doi:10.15537/smj.2022.43.4.20210905 · Cited by 23 · see citing works

Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial

Takuva, S. G., Takalani, A., Seocharan, I., Yende‐Zuma, N., Reddy, T., Engelbrecht, I., Faesen, M., Khuto, K., Whyte, C., Bailey, V. C., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1004024 · Cited by 23 · see citing works

The change in glycaemic control immediately after COVID‐19 vaccination in people with type 1 diabetes

Heald, A. H., Stedman, M., Horne, L., Rea, R. D., Whyte, M., Gibson, M., Anderson, S. G., & Ollier, W. (2021) · Diabetic Medicine · doi:10.1111/dme.14774 · Cited by 22 · see citing works

Humoral and cellular immune response over 9 months of mRNA-1273, BNT162b2 and ChAdOx1 vaccination in a University Hospital in Spain

Fernández-Ciriza, L., González, Á., del Pozo, J. L., Fernández‐Montero, A., Carmona-Torre, F., Carlos, S., Sarasa, M. D. M., & Reina, G. (2022) · Scientific Reports · doi:10.1038/s41598-022-19537-2 · Cited by 18 · see citing works

Analysis of continuous glucose tracking data in people with type 1 diabetes after COVID‐19 vaccination reveals unexpected link between immune and metabolic response, augmented by adjunctive oral medication

Heald, A. H., Rea, R. D., Horne, L., Metters, A., Steele, T., Leivesley, K., Whyte, M., Stedman, M., & Ollier, W. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14714 · Cited by 17 · see citing works

Determinants of the Development of SARS-CoV-2 Anti-Spike Immune-Response after Vaccination among Healthcare Workers in Egypt

El‐Ghitany, E. M., Hashish, M. H., Farag, S., Omran, E. A. H., Farghaly, A. G., & Azzam, N. F. A. E. M. (2022) · Vaccines · doi:10.3390/vaccines10020174 · Cited by 16 · see citing works

Side effects among healthcare workers from a large Milan university hospital after second dose of BNT162b2 mRNA COVID-19 vaccine

Borroni, E., Consonni, D., Cugno, M., Lombardi, A., Mangioni, D., Bono, P., Oggioni, M., Renteria, S. U., Bordini, L., Nava, C. D., et al. (2021) · La Medicina del Lavoro · doi:10.23749/mdl.v112i6.12507 · Cited by 14 · see citing works

Uncommon Side Effects of COVID-19 Vaccination in the Pediatric Population

Pandit, T., Pandit, R., & Goyal, L. (2022) · Cureus · doi:10.7759/cureus.30276 · Cited by 14 · see citing works

Humoral Responses to Single-Dose BNT162b2 mRNA Vaccination in Dialysis Patients Previously Infected With SARS-CoV-2

Speer, C., Morath, C. P., Töllner, M., Buylaert, M., Göth, D., Nußhag, C., Kälble, F., Schaier, M., Grenz, J., Kreysing, M., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.721286 · Cited by 13 · see citing works

Possible Association between Vogt-Koyanagi-Harada Disease and Coronavirus Disease Vaccine: A Report of Four Cases

Ferreira, F. D. Q. T., Araújo, D. C., de Albuquerque, L. M., Bianchini, P. M., de Holanda, E. C., & Pugliesi, A. (2022) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2022.2093756 · Cited by 13 · see citing works

Adverse events reported after administration of BNT162b2 and mRNA-1273 COVID-19 vaccines among hospital workers: a cross-sectional survey-based study in a Spanish hospital

Valera-Rubio, M., Sierra-Torres, M. I., García, R. C., Ramos, J., López-Márquez, M. R., Cruz-Salgado, Ó., & Calleja‐Hernández, M. Á. (2022) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2022478 · Cited by 13 · see citing works

SARS-CoV-2 pathophysiology and post-vaccination severity: a systematic review

Rustagi, V., Gupta, S. R. R., Talwar, C., Singh, A., Xiao, Z.-Z., Jamwal, R., Bala, K., Bhaskar, A. K., Nagar, S., & Singh, I. K. (2024) · Immunologic Research · doi:10.1007/s12026-024-09553-x · Cited by 12 · see citing works

Serum antibody response to BNT162b2 after natural SARS‐CoV‐2 infection

Perkmann, T., Perkmann‐Nagele, N., Köller, T., Mucher, P., Radakovics, A., Wolzt, M., Wagner, O. F., Binder, C. J., & Haslacher, H. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13632 · Cited by 11 · see citing works

Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT): Protocol for a Multisite Longitudinal Cohort Study

Burns, J., Rivers, P. S., LeClair, L. B., Jovel, K. S., Rai, R. P., Lowe, A. A., Edwards, L., Khan, S. R., Mathenge, C., Ferraris, M., et al. (2022) · JMIR Research Protocols · doi:10.2196/37929 · Cited by 10 · see citing works

SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings

Saluzzo, F., Mantegani, P., de Chaurand, V. P., Quaresima, V., Cugnata, F., Serio, C. D., Macé, A., de Vos, M., Sacks, J. A., & Cirillo, D. M. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00250-21 · Cited by 10 · see citing works

Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents

Chong, Y., Tani, N., Goto, T., Yonekawa, A., Ikematsu, H., Shimono, N., Tanaka, Y., & Akashi, K. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.10.011 · Cited by 10 · see citing works

Could Vaccine Dose Stretching Reduce COVID-19 Deaths?

Więcek, W., Ahuja, A., Kremer, M. R., Gomes, A. S., Snyder, C. M., Tabarrok, A. T., & Tan, B. J. (2021) · National Bureau of Economic Research · doi:10.3386/w29018 · Cited by 9 · see citing works

Neutralizing antibodies levels are increased in individuals with heterologous vaccination and hybrid immunity with Ad5-nCoV in the north of Mexico

Cervantes-Luévano, K., Espino‐Vázquez, A. N., Flores-Acosta, G. I., Bernáldez-Sarabia, J., Cabanillas-Bernal, O., Gasperin-Bulbarela, J., González-Sánchez, R., Comas‐García, A., & Licea-Navarro, A. F. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269032 · Cited by 8 · see citing works

The SARS-CoV-2 Antibodies, Their Diagnostic Utility, and Their Potential for Vaccine Development

Hajissa, K., Mussa, A., Karobari, M. I., Abbas, M. A., Ibrahim, I. K., Assiry, A. A., Iqbal, A., Alhumaid, S., Mutair, A. S. A., Rabaan, A. A., et al. (2022) · Vaccines · doi:10.3390/vaccines10081346 · Cited by 6 · see citing works

How Humoral Response and Side Effects Depend on the Type of Vaccine and Past SARS-CoV-2 Infection

Stępień, M., Zalewska, M., Knysz, B., Świątoniowska-Lonc, N., Jankowska‐Polańska, B., Łaczmański, Ł., Piwowar, A., & Kuźniarski, A. (2022) · Vaccines · doi:10.3390/vaccines10071042 · Cited by 6 · see citing works

One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection

Dimeglio, C., Hérin, F., Miédougé, M., Da-Silva, I., Porcheron, M., Martin‐Blondel, G., Soulat, J., & Izopet, J. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.06.016 · Cited by 6 · see citing works

Self-reported side effects of COVID-19 vaccines among the public

Karuppannan, M., Ming, L. C., Wahab, M. S. A., Noordin, Z. M., Yee, S., & Hermansyah, A. (2024) · Journal of Pharmaceutical Policy and Practice · doi:10.1080/20523211.2024.2308617 · Cited by 5 · see citing works

COVID-19 Enfeksiyonu Geçiren ve Geçirmeyen Sağlık Çalışanlarında İki Doz İnaktive SARS-CoV-2 Aşısı Sonrası Antikor Yanıtı: Prospektif Gözlemsel Çalışma

Özgür, D., & Tütüncü, E. E. (2022) · Mikrobiyoloji Bulteni · doi:10.5578/mb.20229904 · Cited by 5 · see citing works

Evaluation of eight lateral flow tests for the detection of anti-SARS-CoV-2 antibodies in a vaccinated population

Greenland-Bews, C., Byrne, R. L., Owen, S. I., Watkins, R. L., Bengey, D., Buist, K., Clerkin, K., Escadafal, C., Finch, L. S., Gould, S., et al. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08033-1 · Cited by 5 · see citing works

Diagnostic performance of two serological assays for the detection of SARS-CoV-2 specific antibodies: surveillance after vaccination

Fresco‐Taboada, A., García-Durán, M., Aira, C., López, L., Sastre, P., van der Hoek, L., van Gils, M. J., Brouwer, P. J. M., Sanders, R. W., Holzer, B., et al. (2022) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2022.115650 · Cited by 5 · see citing works

Evaluation of Side Effects Following COVID-19 Vaccination in Saudi Arabia’s General Population

Bakhuraysah, M. M., Bukhari, A. A., Gharib, A. F., & Alharbi, A. D. (2024) · Annals of Pharmacy Practice and Pharmacotherapy · doi:10.51847/1lblztvhfo · Cited by 4 · see citing works

Health Consequences of University Employees Post-COVID-19 Vaccination at Palestinian Universities

Shouli, M. M., Ayed, A., Shouli, K. M., Issa, B. M., & Khraiwesh, I. (2022) · SAGE Open Nursing · doi:10.1177/23779608221144935 · Cited by 4 · see citing works

Neutralizing Antibody Responses to Messenger RNA Coronavirus Disease 2019 Vaccines Versus Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Pregnant Women and Vaccine-Induced Antibody Transfer to Infants

Dawood, F. S., Tita, A., Stockwell, M. S., Newes‐Adeyi, G., Wielgosz, K., Gyamfi‐Bannerman, C., Battarbee, A. N., Reichle, L., Thornburg, N. J., Ellington, S., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad204 · Cited by 4 · see citing works

Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study)

Sáez‐Peñataro, J., Torres, F., Bartra, J., Bascuas, J., Vilella, A., Tortajada, M., Quesada, S., González, E., López‐Suñé, E., Castells, A., et al. (2022) · BioDrugs · doi:10.1007/s40259-022-00543-9 · Cited by 3 · see citing works

Adverse Reactions after Booster SARS-CoV-2 Vaccination Have Less Impact on Antibody Response than after Basic Vaccination Scheme

Kanizsai, A., Závori, L., Molnár, T., Tökés‐Füzesi, M., Szalai, Z., Berecz, J., Várnai, R., Péterfi, Z., Schwarcz, A., & Csécsei, P. (2023) · Vaccines · doi:10.3390/vaccines11010182 · Cited by 3 · see citing works

Durability of Viral Neutralization in Asymptomatic Coronavirus Disease 2019 for at Least 60 Days

Haymond, A., Damluji, A. A., Narayanan, A., Mueller, C., Reeder, A., Alem, F., Maxwell, G., Petricoin, E., Liotta, L., & Defilippi, C. (2021) · Journal of Infectious Diseases · doi:10.1093/infdis/jiab140 · Cited by 3 · see citing works

Neutralizing antibodies and T-cell responses to inactivated SARS-CoV-2 vaccine in COVID-19 convalescents one and a half years after infection

Yan, L., Li, D., Wang, Z., Jiang, Z., Xiao, X., & Yu, X. (2022) · Virus Research · doi:10.1016/j.virusres.2022.198977 · Cited by 2 · see citing works

Africa's Knowledge Bridge

Osuagwu, U. L., Agho, K. E., Ekpenyong, B. N., Mashige, K. P., & Ishaya, T. (2024) · doi:10.61588/vbox7053 · Cited by 2 · see citing works

Adverse effects and SARS-CoV-2 infection after COVID-19 vaccination among the vaccinated people of Bangabandhu Sheikh Mujib Medical University Hospital in Dhaka, Bangladesh: a pilot study

Sharmin, E., Majumder, K., & Ahmed, S. F. (2025) · Scientific Reports · doi:10.1038/s41598-025-12690-4 · Cited by 2 · see citing works

[COVID-19 vaccination: the reality after clinical trials].

Ruiz-Galiana, J., Cantón, R., Ramos, P. D. L., García-Botella, A., García-Lledó, A., Gómez-Pavón, J., Castillo, J. G. D., Hernández-Sampelayo, T., Martín-Delgado, M. C., Sánchez, F. J. M., et al. (2021) · Revista Espanola de Quimioterapia · doi:10.37201/req/035.2021 · Cited by 5 · see citing works

COVID-19 Vaccination within the Context of Reactogenicity and Immunogenicity of ChAdOx1 Vaccine Administered to Teachers in Poland

Gańczak, M., Korzeń, M., Sobieraj, E., Goławski, J., Pasek, O., & Biesiada, D. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19053111 · Cited by 2 · see citing works

Corbevax Vaccine Side Effects in Children of Age Group 12–14 Years: A Prospective Observational Study

Pushkar, K., Bobdey, S., Kotoki, R., Koundinya, K., Michael, P., & Kaushik, S. K. (2023) · Journal of Marine Medical Society · doi:10.4103/jmms.jmms_135_22 · Cited by 1 · see citing works

Evolving COVID-19 Pandemic: The Lurking Dangers and Pillars of Hope

Nikhra, V. (2021) · Annals of Immunology & Immunotherapy · doi:10.23880/aii-16000135 · Cited by 1 · see citing works

CoronaVac Aşısının İkinci Dozu COVID-19 Geçirmiş Kişilerde Antikor Düzeylerinin Düşmesine Neden Olabilir

Topkaya, A. E., KESKIN, A. Ü., Dalan, A. B., & Çıragil, P. (2022) · Mikrobiyoloji Bulteni · doi:10.5578/mb.20229913 · Cited by 1 · see citing works

Adverse events associated with COVID-19 treatment and their possible relationship with patient characteristics: A narrative review

Alshargi, O., Alzaid, S. M., Al-Dosari, B. S., & Alzubaidi, A. S. (2023) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2023.105521 · Cited by 1 · see citing works

SARS-CoV-2 Vaccine-Induced Antibody Response and Reinfection in Persons with Past Natural InfectionPreprint

Chauhan, N., Chahar, A. S., Singh, P. K., Bhavesh, N. S., Tandon, R., & Chaturvedi, R. (2021) · medRxiv · doi:10.1101/2021.05.18.21257259

Safety, Tolerability and Immunogenicity of Oxford-AstraZeneca ChAdOx1 Vaccine Among Polish School-TeachersPreprint

Gańczak, M., Korzeń, M., Sobieraj, E., Goławski, J., Pasek, O., & Biesiada, D. (2021) · Research Square · doi:10.21203/rs.3.rs-1141544/v1

Ten Commonly Asked Questions About COVID-19 Vaccines from a Group of the Saudi Population, King Abdulaziz Medical City, Riyadh

Altulaihi, B. A., Eraij, S. M. A., Salamah, G. M., Alshahrani, T. M., Haikel, K. A. B., Alilaj, M. O., Alzaid, T. A., & Alsaeed, R. R. (2022) · Asian Journal of Pharmaceutical Research and Health Care · doi:10.4103/ajprhc.ajprhc_61_22

COVID-19 anti immunoglobulin G antibodies serum levels among health care workers post COVID -19 vaccination: A single center study

Saad, S. (2023) · Egyptian journal of Immunology · doi:10.55133/eji.300404

COVID-19 Vaccines Side-Effects and Reaction Among Vaccinated Population in Saudi Arabia

Bakhuraysah, M. M., Bukhari, A. A., Gharib, A. F., & Alharbi, A. D. (2023) · Archives of Pharmacy Practice · doi:10.51847/khntseqjwk

Additional file 2 of The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa

Osuagwu, U. L., Mashige, K. P., Ovenseri-Ogbomo, G., Envuladu, E. A., Abu, E. K., Miner, C. A., Timothy, C. G., Ekpenyong, B. N., Langsi, R., Amiebenomo, O. M.-A., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22606067

Additional file 1 of The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa

Osuagwu, U. L., Mashige, K. P., Ovenseri-Ogbomo, G., Envuladu, E. A., Abu, E. K., Miner, C. A., Timothy, C. G., Ekpenyong, B. N., Langsi, R., Amiebenomo, O. M.-A., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22606064

In Previously Infected Persons, Is One Dose of mRNA COVID-19 Vaccine Enough?

Sahly, H. M. E. (2021) · Journal watch · doi:10.1056/nejm-jw.na53314

Is a single dose of mRNA vaccine sufficient for COVID‐19 survivors?

Malek, A. E., Dagher, H., Hachem, R. Y., Chaftari, A., & RAAD, I. I. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26915 · Cited by 2 · see citing works

Mounting evidence for immunizing previously infected subjects with a single dose of SARS-CoV-2 vaccine

Marc, G. P., Álvarez-Paggi, D., & Polack, F. P. (2021) · Journal of Clinical Investigation · doi:10.1172/jci150135 · Cited by 15 · see citing works

P-2054. Effectiveness of a Single COVID-19 mRNA Vaccine Dose in Individuals Previously Infected with SARS-CoV-2: A Systematic Review

Volkman, H. R., Nguyen, J. L., Mustapha, M. M., Yang, J., Jódar, L., & McLaughlin, J. M. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae631.2210

Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine

Krammer, F., Srivastava, K., the PARIS team, & Simon, V. (2021) · doi:10.1101/2021.01.29.21250653 · Cited by 116 · see citing works